• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

Immediate Office of the Director (IOD) of OCBQ


The Immediate Office of the Director (IOD) of OCBQ has many responsibilities, including the following:


The Immediate Office of the Director (IOD) within OCBQ provides leadership and administrative oversight for the Office's multifaceted activities and organizational responsibilities, including in such areas as:

  • policy making,
  • program direction and coordination,
  • liaison responsibilities,
  • and providing subject matter expert advice to the Center Director and other Agency officials in support of CBER's inspection, compliance and surveillance related activities, and its science-based regulatory work.


Compliance-Related Policy Activities


The IOD staff within OCBQ participate in and contribute to a wide variety of compliance-related policy and science-based regulatory activities, including the following:


  • Contributes to policy development within CBER, as well across other FDA Centers, including the development of guidance documents, rulemaking, SOPPs, Compliance Policy Guides, and FDA Staff Manual Guides.
  • Conducts policy analyses and reviews, including the review and clearance of OCBQ-authored policy documents, white papers, charters, and strategic plans.
  • Participates in Intra-Agency, Inter-Agency, and Intra-Center working groups.



Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002